ctDNA Monitoring
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment (NCT07366112) | Peking University People's Hospital | 2026-04-20 |
| Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer (NCT07292207) | Nagoya City University | 2026-01-10 |
| ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer (NCT06970912) | Peking University People's Hospital | 2025-08-01 |
| Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention (NCT05635630) | Fudan University | 2022-06-24 |
Track ctDNA Monitoring automatically
Every clearance here is in the API, with alerts when new ones post.